BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

Peninsula Health Forges New Model for Healthcare Delivery with Citrix® and Logicalis

When COVID-19 began sweeping the globe, Australia was quick to lockdown. And Peninsula Health was equally quick to respond. With the help of ...

August 12, 2021 | News

Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021

Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes place&nb...

August 11, 2021 | News

Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine

Delivery to begin in the second half of September -Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...

August 11, 2021 | News

Australia Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster

Growing concern among Australian cancer organisations that ongoing COVID-19 lockdowns, and delays in routine procedures are causing cancer 'symptom ...

August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

August 06, 2021 | News

$3.3 million to support Australians living with a rare disease

The Morrison Government is providing $3.3 million to support the approximate two million Australians living with a rare disease, providing them with suppor...

August 02, 2021 | News

Lupin Acquires Southern Cross Pharma in Australia

Incorporated in Melbourne, Australia, SCP is engaged in developing, registering, and distributing generic products. As a part of the transaction, Generic H...

July 30, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant

New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally signif...

July 28, 2021 | News

DePuy Synthes Unveils VELYS™ Robotic-Assisted Solution In Australia

Australian orthopaedic surgeons to be among the first in the world to access DePuy Synthes’ VELYS Robotic-Assisted Solution, which has recently been ...

July 20, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

July 08, 2021 | News

Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara

Alvotech, today, announced that the first patient has been dosed in the comparative, confirmatory efficacy and safety clinical study (AVT04-GL-301) for AVT...

July 06, 2021 | News

Alterity Therapeutics granted a new US patent

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the granting of a new composition of matter patent by the ...

July 02, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

July 01, 2021 | News

Stay Connected